The CARING Study: Creating and Restoring Health Through Nutrition Guidance
Physicians Committee for Responsible Medicine · with Blue Cross Blue Shield, Mayo Clinic · NCT05795439
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 700
- US sites recruiting
- 1
- Study start
- July 11, 2023
- Record last updated
- April 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The CARING study assesses the health benefits of nutrition education for Blue Cross Blue Shield subscribers, as well as potential healthcare cost savings to subscribers and the insurance company.
Being studied: Low-fat, vegan diet
Conditions: Type2diabetes; Type 2 Diabetes Treated With Insulin
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Blue Cross Blue Shield subscriber continuously enrolled for the prior 12 months
- Male or female
- Age at least 18 years
- Have a diagnosis of type 2 diabetes
- Ability and willingness to participate in all components of the study, including:
- Following a plant-based diet for the initial 16 weeks of the study;
- Attending weekly online classes for the initial 16 weeks of the study; and
- Keeping physical activity level consistent throughout the initial 16 weeks of the study.
Exclusion Criteria
- Diabetes mellitus type 1 or history of any endocrine condition that would affect body weight, such as a pituitary abnormality or Cushing's syndrome
- Smoking during the past six months
- Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
- Current or unresolved past drug abuse
- Recently gave birth, pregnant, or plans to become pregnant before or during the study period
- Unstable medical or psychiatric status
- Cancer diagnosis
- Chronic kidney disease, stage 4 or 5
- Evidence of an eating disorder
- Lack of English fluency
- Bariatric surgery in the last 6 months
- Dementia
- Institutional custodial care
- End of life
- Palliative Care
- Actively engaged in specific BCBSM diabetes programs and case management programs
Recruiting US locations
Physicians Committee for Responsible Medicine
Washington D.C., DC 20016
Site contact: Physicians CFR Medicine · 2025277363 · ajayaraman@pcrm.org
Study contacts (from the official record)
- Macy Sutton, MS · 202-527-7363 · msutton@pcrm.org
- Arathi Jayaraman · ajayaraman@pcrm.org
Similar studies in District of Columbia
All diabetes studies in District of Columbia →- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Washington D.C., DC + 57 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Morphic Medical Inc.
- Location
- Washington D.C., DC + 25 other US sites
- Eligibility basics
- Ages 22–65
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Hoffmann-La Roche
- Location
- Washington D.C., DC + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Washington D.C., DC + 39 other US sites
- Eligibility basics
- Ages 10–17